The Latest in FDA Evaluations and Research

FDA News


Latest News from FDA News
Avalanche International Corp (OTCQB: AVLP), announced that its previously approved 2-for-1 split of its common stock has taken effect today. The split had a payment date of yesterday and a record date of August 22, 2014. The Company seeks to provide investors an enhanced liquidity due ...
TUCSON, Ariz., Aug. 26, 2014 /PRNewswire/ -- SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, is high on the Inc. 5000 named by the business magazine Inc.
RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 26, 2014 /PRNewswire/ -- Jardiance® (empagliflozin) tablets are now available by prescription in pharmacies across the United States, including Walgreens, Rite Aid, Kroger and many other leading chain and independent retailers, according to Boeh...
ALISO VIEJO, Calif., Aug. 26, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the enrollment of the first patient into a phase II study to evaluate the efficacy, safety and tolerability of AVP-786 for the adjunctive treatment of major depressive disorde...
LiveWire Ergogenics Inc. (OTCQB: LVVV), through its international partner, Lu'an Kaixuan Hemp Company Ltd., has obtained Chinese government approval for CBD (Cannabidiol) extraction from industrial hemp in China. This landmark approval is believed to be the first time a partnership bet...
TORONTO, Aug. 26, 2014 /PRNewswire/ - Apotex Inc., the largest Canadian owned pharmaceutical company, announced today that an arbitration tribunal rejected Apotex's claims that the FDA violated NAFTA by prohibiting imports of Apotex products from two plants in Ontario, Canada.
VeriTeQ Corporation (“VeriTeQ”) (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it will host a conference call on Wednesday, September 3, 2014, at 10 a.m. ET, to u...
Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patented-protected and FDA-cleared collagen product, CellerateRX®, announced that its 2014 Annual Meeting of Shareholders will be held at the Company's corporate offices ...
WASHINGTON, Aug. 26, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ:  TROV) presented data at the Next Generation Dx Summit; Moving Assays to the Clinic with an oral presentation entitled "Targeted Detection and Monitoring of Cell Free Tumor DNA in Urine." In this presentation Trovagene ...
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that a poster presentation including Phase 2 clinical data on its lead drug candidate,...
Matica Enterprises Inc. (CSE: GRF)(FRANKFURT: 39N) ("Matica" or the "Company") is pleased to announce it has signed a definitive agreement with Bellerosa Distributing Ltd. ("Bellerosa") to exclusively market the full range of GlobalEx tablets for use in Canadian and US horticultural an...
MOUNTAIN VIEW, Calif., Aug. 26, 2014 /PRNewswire/ -- Based on its recent analysis of the breast imaging solutions market, Frost & Sullivan recognizes Volpara Solutions with the 2014 North American Frost & Sullivan Award for Technology Innovation Leadership. Volpara Solutions of...
Matica Enterprises Inc. (CSE:GRF)(FRANKFURT:39N) ("Matica" or the "Company") is pleased to announce it has signed a definitive agreement with Bellerosa Distributing Ltd. ("Bellerosa") to exclusively market the full range of GlobalEx tablets for use in Canadian and US horticultural and ...
SANTA ROSA, Calif., Aug. 26, 2014 /PRNewswire/ -- Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation fr...
Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the company will present at the Morgan Stanley Global Healthcare Conference 2014 to be held September 8-10, 2014 at the Grand Hyatt New York.
LOS ANGELES, Aug. 25, 2014 /PRNewswire/ -- Studies show that, overall, obese patients who have had laparoscopic sleeve gastrectomy keep the weight off in the long run. At the same time, the procedure is not magic and patients must adjust to their post-surgery body and then develop long...
SHANGHAI, Aug. 25, 2014 /PRNewswire/ -- CPhI, ICSE & BioPh China 2014 and P-MEC, InnoPack & LABWorld China 2014, held on 26th -28th of June hosted by UBM Live and CCCMHPIE and co-organized by UBM Sinoexpo, achieved its successful close at Shanghai New International Expo Centre.
- Leading Global Industry Trends, Lighting up the China Pharmaceutical Dream
Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX), CEN Biotech, today announced that Health Canada Inspectors were present at its facility known as Site 1 (20 North Rear Rd) on July 31, 2014.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Impax Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL) common stock between May 20, 2013 and Jul...
WASHINGTON, Aug. 25, 2014 /PRNewswire-USNewswire/ -- The following is a statement of Susan M. Liss, Executive Director, Campaign for Tobacco-Free Kids:
Pilgrim Quality Solutions, a leading global provider of enterprise quality management software and services for the Life Sciences, today announced that it has been recognized in Gartner’s “Hype Cycle for Life Sciences, 2014.”1
Align Technology, Inc. (NASDAQ: ALGN) today announced that on August 22, 2014, the United States District Court for the Northern District of California dismissed with prejudice the shareholder class action lawsuit filed in November 2012 by lead Plaintiff City of Dearborn Heights Police...
 
NORWALK, Conn., Aug. 25, 2014 /PRNewswire/ -- UBM Medica US announces that EndocrinologyNetwork, a leading online community for endocrinologists and other clinicians who treat patients with T2DM—offers a comprehensive coverage on the SGLT2 inhibitors.
BOSTON, Aug. 25, 2014 /PRNewswire/ -- Raiing Medical Company and the Center for Connected Health at Partners HealthCare initiated a clinical research program to assess the feasibility of the iThermonitor as a clinical support tool in the management of patients with acute leukemia under...
BOONTON, N.J., Aug. 25, 2014 /PRNewswire/ -- With recent arrests adding to the controversy surrounding illegal synthetic growth hormone injections, leading health and bodybuilding supplement provider HGH.com aims to raise awareness of legal, non-synthetic growth hormone supplements and...
WASHINGTON, Aug. 25, 2014 /PRNewswire/ -- On Sunday, August 24, truth®, the nation's largest and longest running youth smoking prevention campaign, premiered the latest advertisements in its new Finish It campaign, titled "Unpaid" and "Response". Both aired during the hugely popular MT...
LONDON, Aug. 25, 2014 /PRNewswire/ -- On August 22, ViiV Healthcare announced that the US Food and Drug Administration (FDA) approved Triumeq® (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.1 Triumeq is ViiV Healthcare's first dolu...
SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Thesan Pharmaceuticals announced today the appointment of Bhaskar Chaudhuri Ph.D., to its Board of Directors. Dr. Chaudhuri has more than 25 years of experience in pharmaceuticals management, drug research & development, and commercializatio...
SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Thesan Pharmaceuticals announced today the appointment of Bhaskar Chaudhuri Ph.D., to its Board of Directors. Dr. Chaudhuri has more than 25 years of experience in pharmaceuticals management, drug research & development, and commercializatio...
PASADENA, Calif., Aug. 25, 2014 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an approximately $9.3 billion total market capitalization real estate investment trust (REIT) uniquely focused on collaborative science and technology campuses in urban innovation cluster...
LAWRENCE, Mass., Aug. 25, 2014 /PRNewswire/ -- NxStage® Medical, Inc., a leading manufacturer of innovative dialysis products, today launched the Nurse Hero Campaign a first-of-its-kind home hemodialysis nurse recognition that honors the dedication and compassion of the nephrology nurs...
RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that results from the Phase 3b exploratory X-VeRT study, investigating the oral Factor Xa inhibitor XARELTO® (rivaroxaban) in patients with non-valvular atrial fibrillation (N...
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that the Company will be a featured presenter at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014 at the New York Palace ...
Novus Acquisition & Development Corp. (PINKSHEETS: NDEV) ("Novus"), developer of healthcare/insurance solutions targeting the medical marijuana industry through its wholly owned subsidiary Novus Medical Group, Inc., today announced the execution of an Exclusive Provider Agreement with ...
PHILADELPHIA, Aug. 25, 2014 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug Administration (FDA) has approved ZORVOLEX® (diclofenac) capsules, a nonste...